journal article·2024-10Open access

Biomedical Metal–Organic Framework Materials: Perspectives and Challenges

Alec Wang, Madeline Walden, Romy Ettlinger, Fabian Kiessling, Jeremiah J. Gassensmith, Twan Lammers, Stefan Wuttke, Quim Peña

Advanced Functional Materials· Volume 34· Issue 43

Abstract

Abstract Metal–organic framework (MOF) materials are gaining significant interest in biomedical research, owing to their high porosity, crystallinity, and structural and compositional diversity. Their versatile hybrid organic/inorganic chemistry endows MOFs with the capacity to retain organic (drug) molecules, metals, and gases, to effectively channel electrons and photons, to survive harsh physiological conditions such as low pH, and even to protect sensitive biomolecules. Extensive preclinical research has been carried out with MOFs to treat several pathologies and, recently, their integration with other biomedical materials such as stents and implants has demonstrated promising performance in regenerative medicine. However, there remains a significant gap between MOF preclinical research and translation into clinically and societally relevant medicinal products. Here, the intrinsic features of MOFs are outlined and their suitability to specific biomedical applications such as detoxification, drug and gas delivery, or as (combination) therapy platforms is discussed. Furthermore, relevant examples of how MOFs have been engineered and evaluated in different medical indications, including cancer, microbial, and inflammatory diseases is described. Finally, the challenges facing their translation into the clinic are critically examined, with the goal of establishing promising research directions and more realistic approaches that can bridge the translational gap of MOFs and MOF‐containing (nano)materials.
Source: crossref · Quality: baseline

Research context

OpenAlex topics: Metal-Organic Frameworks: Synthesis and Applications · Nanoplatforms for cancer theranostics · Nanoparticle-Based Drug Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

Affiliations

Institute for Experimental Molecular Imaging RWTH Aachen University Hospital Forckenbeckstrasse 55 52074 Aachen Germany

BCMaterials Basque Centre for Materials Applications & Nanostructures Bld. Martina Casiano, 3rd. Floor UPV/EHU Science Park Barrio Sarriena s/n Leioa 48940 Spain

EastChem School of Chemistry University of St Andrews North Haugh St Andrews KY16 9ST UK

The Department of Chemistry and Biochemistry University of Texas at Dallas Richardson TX 75080‐3021 USA

IKERBASQUE Basque Foundation for Science Bilbao 48013 Spain

Funding

European Cooperation in Science and Technology · Bundesministerium für Bildung und Forschung · Deutsche Forschungsgemeinschaft · European Research Council · Welch Foundation · Human Frontier Science Program

References (100+)

Show source-provided references
1. 10.1038/nmat260810.1038/nmat2608 ↗
2. 10.1002/adhm.20210208710.1002/adhm.202102087 ↗
3. 10.1038/s42004-021-00549-410.1038/s42004-021-00549-4 ↗
4. 10.1038/s41563-021-00957-w10.1038/s41563-021-00957-w ↗
5. 10.1038/nature0078510.1038/nature00785 ↗
6. 10.1038/natrevmats.2016.6810.1038/natrevmats.2016.68 ↗
7. 10.1038/4624810.1038/46248 ↗
8. 10.1021/ja981669x10.1021/ja981669x ↗
9. 10.1016/j.biomaterials.2017.01.02510.1016/j.biomaterials.2017.01.025 ↗
10. 10.1021/cr200256v10.1021/cr200256v ↗
11. 10.1016/j.ccr.2015.08.00810.1016/j.ccr.2015.08.008 ↗
12. 10.1016/j.ccr.2021.21439310.1016/j.ccr.2021.214393 ↗
13. 10.1039/D0CS00955E10.1039/D0CS00955E ↗
14. 10.1016/j.addr.2021.02.00510.1016/j.addr.2021.02.005 ↗
15. 10.1038/s41467-020-17755-810.1038/s41467-020-17755-8 ↗
16. 10.1002/anie.20210164410.1002/anie.202101644 ↗
17. 10.1002/anie.20210625910.1002/anie.202106259 ↗
18. 10.1021/ja809459e10.1021/ja809459e ↗
19. 10.1021/acs.chemrev.9b0068510.1021/acs.chemrev.9b00685 ↗
20. 10.1021/acs.chemrev.9b0079710.1021/acs.chemrev.9b00797 ↗
21. 10.1021/acscentsci.0c0067810.1021/acscentsci.0c00678 ↗
22. Scopus database – Document search under scopus.com [accessed on 26th April 2023]. Scopus search details: the search was limited to journal articles between 2010‐2022 (except for Fig. 1f: between 2015‐2022) and the selected keywords (in title abstract or keywords) are as follows;
23. a)Fig. 1a – for MOFs:“metal‐organic framework” OR “metal organic framework”; for MOFs in biomedicine:“metal‐organic framework” OR “metal organic framework” AND (biomedicine OR cancer OR cardiovascular OR brain OR lung OR heart OR microbial OR inflammation OR eye OR wound OR tissue OR bone OR delivery OR disease OR antiinflammatory OR anemia OR overdose OR diabetes);
24. b)Fig. 1b –MOFs in biomedicine keywords(see previous 22a) for Fig 1a)AND (each MOF family);
25. c)Fig. 1c –MOFs in biomedicine keywords(see previous 22a) for Fig 1a)AND (each metal);
26. d)Fig. 1d –MOFs in biomedicine keywords(see previous 22a) for Fig 1a)AND (cancer /microbial OR bacterial / inflammation / wound OR tissue AND regeneration / bone AND regeneration OR osteogenic / diabetes / “brain disease” OR CNS);
27. e)Fig. 1e –MOFs in biomedicine keywords(see previous 22a) for Fig 1a)AND drug delivery;
28. f)Fig. 1f (between 2015–2022)‐drug delivery AND cancer AND (liposo* /hydrogel OR nanogel / micell* / “metal nanoparticle” / microbubble / “metal‐organic framewok” OR “metal organic framework”).
29. 10.1126/science.119216010.1126/science.1192160 ↗
30. 10.1016/j.jcou.2020.10125110.1016/j.jcou.2020.101251 ↗
31. 10.1021/acsomega.2c0426910.1021/acsomega.2c04269 ↗
32. 10.1126/science.123044410.1126/science.1230444 ↗
33. 10.1021/jacs.1c1150710.1021/jacs.1c11507 ↗
34. 10.1126/science.122013110.1126/science.1220131 ↗
35. 10.1038/s41467-017-02600-210.1038/s41467-017-02600-2 ↗
36. 10.1038/s44221-023-00084-710.1038/s44221-023-00084-7 ↗
37. 10.1038/s44221-023-00070-z10.1038/s44221-023-00070-z ↗
38. 10.1021/acsami.6b0090010.1021/acsami.6b00900 ↗
39. 10.1002/adfm.20220772310.1002/adfm.202207723 ↗
40. 10.1007/s00467-011-1838-510.1007/s00467-011-1838-5 ↗
41. 10.1681/ASN.201312126410.1681/ASN.2013121264 ↗
42. 10.1021/jacs.8b1252510.1021/jacs.8b12525 ↗
43. 10.1021/acsami.0c0385910.1021/acsami.0c03859 ↗
44. 10.1021/jacs.8b0443510.1021/jacs.8b04435 ↗
45. 10.1021/acsami.9b0647210.1021/acsami.9b06472 ↗
46. 10.1002/ange.20201251210.1002/ange.202012512 ↗
47. 10.1021/jacs.1c0857610.1021/jacs.1c08576 ↗
48. 10.1021/acsami.9b2224210.1021/acsami.9b22242 ↗
49. 10.1002/adfm.20200805410.1002/adfm.202008054 ↗
50. 10.1038/s41570-021-00275-410.1038/s41570-021-00275-4 ↗
51. 10.1002/advs.20200189910.1002/advs.202001899 ↗
52. Runde T. J. · 2023
53. CDC Radiation Emergencies | Treatments for Radiation Exposure and Contamination 2022.
54. 10.1002/anie.20060187810.1002/anie.200601878 ↗
55. 10.1021/acsami.1c0108910.1021/acsami.1c01089 ↗
56. 10.1016/j.apsb.2021.03.01910.1016/j.apsb.2021.03.019 ↗
57. 10.1002/anie.20190765210.1002/anie.201907652 ↗
58. 10.1016/j.apsb.2018.09.00310.1016/j.apsb.2018.09.003 ↗
59. 10.1021/jacs.9b1163810.1021/jacs.9b11638 ↗
60. 10.1002/anie.20190271410.1002/anie.201902714 ↗
61. 10.1002/smll.20190226810.1002/smll.201902268 ↗
62. 10.1002/smll.20210231510.1002/smll.202102315 ↗
63. 10.3390/molecules2707228810.3390/molecules27072288 ↗
64. 10.1021/acsbiomaterials.1c0087410.1021/acsbiomaterials.1c00874 ↗
65. 10.1021/acsnano.1c0612310.1021/acsnano.1c06123 ↗
66. 10.1021/acsami.2c1845210.1021/acsami.2c18452 ↗
67. 10.1021/acsami.2c0642010.1021/acsami.2c06420 ↗
68. 10.1038/s41598-022-16058-w10.1038/s41598-022-16058-w ↗
69. 10.1002/anie.20190261210.1002/anie.201902612 ↗
70. 10.3390/nano1012249010.3390/nano10122490 ↗
71. 10.1002/adtp.20190012010.1002/adtp.201900120 ↗
72. 10.1016/j.biomaterials.2015.12.01810.1016/j.biomaterials.2015.12.018 ↗
73. 10.1039/C1SC00499A10.1039/C1SC00499A ↗
74. 10.1126/sciadv.aaz610810.1126/sciadv.aaz6108 ↗
75. 10.1021/acs.chemmater.2c0173610.1021/acs.chemmater.2c01736 ↗
76. 10.1021/acs.chemmater.2c0133810.1021/acs.chemmater.2c01338 ↗
77. 10.1021/jacs.8b1270510.1021/jacs.8b12705 ↗
78. 10.1038/ncomms824010.1038/ncomms8240 ↗
79. 10.1021/acsnano.0c1014410.1021/acsnano.0c10144 ↗
80. 10.1007/s40820-020-00423-310.1007/s40820-020-00423-3 ↗
81. 10.1021/jacs.7b1175410.1021/jacs.7b11754 ↗
82. 10.1039/D2SC04982A10.1039/D2SC04982A ↗
83. 10.1073/pnas.221824712010.1073/pnas.2218247120 ↗
84. 10.1021/ja902972w10.1021/ja902972w ↗
85. 10.1002/adfm.20170513710.1002/adfm.201705137 ↗
86. 10.1002/adhm.20220000410.1002/adhm.202200004 ↗
87. 10.1002/adma.20190726710.1002/adma.201907267 ↗
88. 10.1021/jacs.5b1172010.1021/jacs.5b11720 ↗
89. 10.1021/acsnano.8b0341710.1021/acsnano.8b03417 ↗
90. 10.1038/nmat377610.1038/nmat3776 ↗
91. 10.1016/j.jconrel.2017.01.02510.1016/j.jconrel.2017.01.025 ↗
92. 10.1016/j.nano.2021.10248410.1016/j.nano.2021.102484 ↗
93. 10.1038/nrd.2015.110.1038/nrd.2015.1 ↗
94. 10.1039/D1TB01661J10.1039/D1TB01661J ↗
95. 10.1021/acs.jmedchem.7b0047610.1021/acs.jmedchem.7b00476 ↗
96. 10.1021/acscentsci.9b0021610.1021/acscentsci.9b00216 ↗
97. 10.1039/D1TB00847A10.1039/D1TB00847A ↗
98. 10.1111/j.1524-475X.2008.00372.x10.1111/j.1524-475X.2008.00372.x ↗
99. 10.1007/s15010-016-0879-x10.1007/s15010-016-0879-x ↗
100. 10.1002/advs.20200389510.1002/advs.202003895 ↗